Skip to main content
. 2009 Mar 28;373(9669):1083–1096. doi: 10.1016/S0140-6736(09)60318-4

Table 2.

Cause-specific mortality versus baseline BMI in the ranges 15–25 kg/m2 and 25–50 kg/m2

15–25 kg/m2
25–50 kg/m2
Deaths HR (95% CI) Deaths HR (95% CI)
Ischaemic heart disease 7461 1·22 (1·13–1·32) 10 783 1·39 (1·34–1·44)
Stroke 2964 0·92 (0·82–1·03) 3164 1·39 (1·31–1·48)
Other vascular disease 2648 0·84 (0·75–0·95) 3396 1·47 (1·39–1·56)
Diabetes 171 0·96 (0·59–1·55) 393 2·16 (1·89–2·46)
Kidney disease (non-neoplastic) 197 1·14 (0·74–1·77) 217 1·59 (1·27–1·99)
Liver disease (non-neoplastic) 489 0·69 (0·52–0·91) 603 1·82 (1·59–2·09)
Lung cancer 2959 0·71 (0·63–0·79) 2040 0·98 (0·88–1·09)
Upper aerodigestive cancer 685 0·49 (0·39–0·61) 471 0·98 (0·79–1·20)
Other specified cancer 6134 0·94 (0·87–1·02) 6190 1·12 (1·06–1·18)
Respiratory disease* 2426 0·31 (0·28–0·35) 1344 1·20 (1·07–1·34)
Other specified disease 2049 0·62 (0·54–0·71) 1823 1·20 (1·10–1·31)
External cause 2112 0·82 (0·71–0·95) 1720 1·19 (1·08–1·32)
Unknown cause 4961 0·72 (0·66–0·79) 5349 1·22 (1·16–1·28)
All causes 35 256 0·79 (0·77–0·82) 37 493 1·29 (1·27–1·32)

Hazard ratio per 5 kg/m2 higher BMI (HR). HR less than 1 if BMI inversely associated with risk. Analyses exclude the first 5 years of follow-up, and adjust for study, sex, age at risk (in 5-year groups), and baseline smoking status. For analyses restricted to those who had never smoked, see webappendix p 17.

*

HR 0·37 (95% CI 0·30–0·44) in the range 15–25 kg/m2 after exclusion of the first 15 years of follow-up (leaving 956 deaths).

Includes 4113 deaths from cancer of unspecified site.